- Home
- ZS vs ALC Comparison
ZS vs ALC Comparison
Compare ZS & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZS
- ALC
- Stock Information
- Founded
- ZS 2007
- ALC 1945
- Country
- ZS United States
- ALC Switzerland
- Employees
- ZS N/A
- ALC N/A
- Industry
- ZS EDP Services
- ALC Ophthalmic Goods
- Sector
- ZS Technology
- ALC Health Care
- Exchange
- ZS Nasdaq
- ALC Nasdaq
- Market Cap
- ZS 45.3B
- ALC 43.2B
- IPO Year
- ZS 2018
- ALC N/A
- Fundamental
- Price
- ZS $280.27
- ALC $87.86
- Analyst Decision
- ZS Buy
- ALC Buy
- Analyst Count
- ZS 34
- ALC 10
- Target Price
- ZS $296.73
- ALC $106.88
- AVG Volume (30 Days)
- ZS 1.7M
- ALC 1.5M
- Earning Date
- ZS 09-02-2025
- ALC 08-19-2025
- Dividend Yield
- ZS N/A
- ALC 0.25%
- EPS Growth
- ZS N/A
- ALC 6.66
- EPS
- ZS N/A
- ALC 2.25
- Revenue
- ZS $2,546,757,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- ZS $26.35
- ALC $6.75
- Revenue Next Year
- ZS $20.48
- ALC $7.60
- P/E Ratio
- ZS N/A
- ALC $39.13
- Revenue Growth
- ZS 25.46
- ALC 3.80
- 52 Week Low
- ZS $153.45
- ALC $80.48
- 52 Week High
- ZS $318.46
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- ZS 37.14
- ALC 47.15
- Support Level
- ZS $280.00
- ALC $89.94
- Resistance Level
- ZS $292.00
- ALC $91.61
- Average True Range (ATR)
- ZS 6.35
- ALC 1.50
- MACD
- ZS -1.34
- ALC -0.08
- Stochastic Oscillator
- ZS 30.85
- ALC 33.29
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.